Duke Street considers Biomnis exit

The business could be valued in the €300-400m range, the spokesperson added. Potential suitors reportedly include 3i and PAI Partners. Duke Street acquired Biomnis for €217m in 2008.

Biomnis, formerly Laboratoire Marcel Mérieux, was founded in 1897. The company carries out specialised biological analysis on behalf of laboratories as well as private clinics and public hospitals. The company specialises in molecular diagnostics, tissue, fertility treatment and biochemistry.

The group has two main sites in Lyon and Paris, as well facilities in Bordeaux, Dublin and Dubai. The company reported turnover of €240m in 2011 (against €220m at the time of Duke Street's investment) and employs in excess of 1,700 people.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Exits
• Healthcare
• France
• Credit Suisse
• Duke Street